AU2002233969A1 - Vaccines and antibodies produced from viruses derived from an immortal cell line of grouper epinephelus coioides - Google Patents

Vaccines and antibodies produced from viruses derived from an immortal cell line of grouper epinephelus coioides

Info

Publication number: AU2002233969A1
Authority: AU; Australia
Prior art keywords: vaccines; cell line; antibodies produced; immortal cell; viruses derived
Prior art date: 2001-12-07
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2002233969A

Inventor

Shau-Chi Chi

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Schweitzer Chemical Corp

Original Assignee

Schweitzer Chemical Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-12-07

Filing date

2001-12-07

Publication date

2003-06-23

2001-12-07 Application filed by Schweitzer Chemical Corp filed Critical Schweitzer Chemical Corp

2003-06-23 Publication of AU2002233969A1 publication Critical patent/AU2002233969A1/en

Status Abandoned legal-status Critical Current

Links

241000357444 Epinephelus coioides Species 0.000 title 1
241000700605 Viruses Species 0.000 title 1
229960005486 vaccine Drugs 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/10011—Birnaviridae
- C12N2720/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/30011—Nodaviridae
- C12N2770/30022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Virology (AREA)
Biophysics (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Medicinal Chemistry (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biochemistry (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

AU2002233969A 2001-12-07 2001-12-07 Vaccines and antibodies produced from viruses derived from an immortal cell line of grouper epinephelus coioides Abandoned AU2002233969A1 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
PCT/US2001/046177 WO2003050142A1 (en)	2001-12-07	2001-12-07	Vaccines and antibodies produced from viruses derived from an immortal cell line of grouper epinephelus coioides

Publications (1)

Publication Number	Publication Date
AU2002233969A1 true AU2002233969A1 (en)	2003-06-23

Family

ID=21743066

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2002233969A Abandoned AU2002233969A1 (en)	2001-12-07	2001-12-07	Vaccines and antibodies produced from viruses derived from an immortal cell line of grouper epinephelus coioides

Country Status (3)

Country	Link
AU (1)	AU2002233969A1 (en)
NO (1)	NO20042854L (en)
WO (1)	WO2003050142A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TWI347364B (en)	2003-02-19	2011-08-21	Novartis Ag	Inactivated nodavirus vaccine
IL230970A0 (en)	2014-02-13	2014-09-30	Univ Ramot	Tilapia lake virus vaccines
CN114057841A (en)	2014-12-15	2022-02-18	纽约市哥伦比亚大学理事会	Novel tilapia mossambica virus and use thereof
CN104725503B (en) *	2015-03-31	2018-08-17	华中农业大学	A kind of Fugu rubripes nervous necrosis virus capsid protein Yolk antibody and its application
KR101884069B1 (en)	2016-08-25	2018-07-31	전남대학교산학협력단	Monoclonal antibody against nervous necrosis virus and use thereof
WO2018147630A1 (en) *	2017-02-10	2018-08-16	부경대학교 산학협력단	Method for producing fish virus
CN111378033A (en) *	2020-03-05	2020-07-07	中国海洋大学	Monoclonal antibody for resisting nervous necrosis virus and preparation method thereof
CN117143806B (en) *	2023-10-18	2024-02-23	华南农业大学	Cell line of garrupa fries, construction method and application thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK151087A (en) *	1987-03-25	1988-09-26	Kurt Baekgaard Osther	METHOD FOR DETECTION OF HIV (HTLV III / LAV) VIRAL ANTIGENS IN CELLS, SERUM AND OTHER BODY FLUIDS
TWI220904B (en) *	1998-12-03	2004-09-11	Nat Science Council	An immortal cell line derived from grouper Epinephelus coioides and its applications therein

2001
- 2001-12-07 AU AU2002233969A patent/AU2002233969A1/en not_active Abandoned
- 2001-12-07 WO PCT/US2001/046177 patent/WO2003050142A1/en not_active Application Discontinuation
2004
- 2004-07-06 NO NO20042854A patent/NO20042854L/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
NO20042854L (en)	2004-09-06
WO2003050142A1 (en)	2003-06-19

Similar Documents

Publication	Publication Date	Title
HUP0402164A3 (en)	2010-01-28	Polycistronic expression of antibodies
AU2003235707A1 (en)	2003-07-30	Immunogenic preparations and vaccines on the basis of mrna
AU2002252731A1 (en)	2002-11-11	Compositions and methods of double-targeting virus infections and cancer cells
AU2002340167A1 (en)	2003-06-17	Anti-hla-dr antibodies and the methods of using thereof
AU2002348151A1 (en)	2003-05-19	Viral vector production methods and compositions
EP1575601A4 (en)	2010-08-04	Recombinant vaccine viruses expressing il-15 and methods of using the same
AU2002233969A1 (en)	2003-06-23	Vaccines and antibodies produced from viruses derived from an immortal cell line of grouper epinephelus coioides
AU2002225509A1 (en)	2003-06-17	Production and of viruses, viral isolates and vaccines
AU2003259374A1 (en)	2004-03-19	Vaccine comprising il-13 and an adjuvant
AU2003278175A1 (en)	2004-04-23	Vaccines of enhanced immunogenicity, and methods for preparing such vaccines
AU2002342285A1 (en)	2003-05-19	Securing and handling of mail
AU2002347464A1 (en)	2003-01-02	Anti-arthropod vector vaccines methods of selecting and uses thereof
WO2005049814A3 (en)	2006-08-17	Novel atypical pneumonia-causing virus
IL141443A0 (en)	2002-03-10	Vaccine comprising cytokine-induced heat shock proteins (hsp)
AU2002366544A1 (en)	2003-06-23	Adjuvant formulations for bacterial and virus vaccines and method of making same
AU2001267239A1 (en)	2002-01-08	Viral phospholipase a2 enzymes, anti-viral agents and methods of use
AU2002318104A1 (en)	2002-11-25	Microparticles and methods for delivery of recombinant viral vaccines
AU2003301865A1 (en)	2004-06-07	Epitopes of hepatitis c virus
AU2002320079A1 (en)	2002-12-23	Vaccines, immunotherapeutics and methods of using the same
AU2003287216A1 (en)	2004-05-13	Gb virus c and methods of treating viral infections
AU2002254431A1 (en)	2002-10-08	Antibodies against autoantigens of primary biliary cirrhosis and methods of making and using them
AU2002217820A1 (en)	2003-04-01	Method and compositions of defensin-antigen fusion proteins and chemokine-antigen fusion proteins as vaccines for tumors and viral infection
AU2003246485A1 (en)	2004-02-02	Interactions of the epstein-barr virus protein ebna1, and uses thereof
AU3364000A (en)	2000-08-29	Antigen of erysipelothirx rhusiopathiae comprising an immuno-protective epitope
AU2002323598A1 (en)	2003-03-24	Measles vaccine vectors and methods of use

Legal Events

Date	Code	Title	Description
2004-08-26	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase